Who founded electroCore, Inc.?

electroCore, Inc. was founded by JP Errico.

Who are electroCore, Inc.'s investors?

electroCore, Inc.'s investors include Foothill Ventures, Tullis Health Investors, Merck Global Health Innovation Fund, Tullis.

How much funding has electroCore, Inc. raised?

electroCore, Inc. has disclosed $86.8M raised across 10 of its 16 known rounds.

Where is electroCore, Inc. headquartered?

electroCore, Inc. is headquartered in Basking Ridge, US.

electroCore, Inc.

NASDAQ: ECOR

Basking Ridge, US · Delaware corporation · 4 known investors

Find your way into electroCore, Inc.

484 people in our graph share verified history with the electroCore, Inc. team — schools, employers, funds. One of them is your warm intro.

Mark Siegelunlockedknows JP Errico · together at Massachusetts Institute of Technology (overlapped)

×3knows the team · via Duke University

×5knows the team · via Massachusetts Institute of Technology

×2knows the team · via Duke University School of Law

knows the team · via Pepperdine Graziadio Business School

electroCore develops non-invasive vagus nerve stimulation (nVNS) medical devices, marketed as gammaCore, to treat patients suffering from pain and chronic conditions. The company operates in the bioelectronic medicine field and sells its products in markets including the US, UK, EU countries, Canada, Australia, New Zealand, and Saudi Arabia.

Biotech Digital Health Hardware Healthtech Medical Devices

Founders & leadership

JP Errico inFounder · Board of Directors2019–2023JP Errico is a founder of electroCore who developed the company's intellectual property portfolio for vagus nerve stimulation. He holds an undergraduate degree in aeronautical engineering from MIT and graduate degrees in law and mechanical/materials engineering from Duke University, and has previously founded or held senior roles at multiple medical device and pharmaceutical companies.

Brian PosnerinChief Financial Officer

Daniel S. GoldbergerExecutive

Peter StaatsinChief Medical Officer

Frank Amato inExecutiveFrank Amato is a biotech and medical device executive who previously served as CEO of electroCore, where he led the commercialization of gammaCore and secured FDA clearances for the nVNS treatment. He has held senior leadership roles at major pharmaceutical companies including Merck, Schering Plough, Ligand Pharmaceuticals, Pfizer, and Pharmacia Corporation, and most recently served as CEO of Synaps Dx.

Board

Trevor MoodyBoard director

Jim Tullis inBoard directorFounding Partner at Tullis Health Investors

Peter CuneoBoard director

Julie A. GoldsteinBoard director

Thomas M. PattonBoard director

Thomas J. ErricoBoard director

John P. GandolfoBoard director

Investors · 4

Foothill VenturesLos Altos · $100K – $10M

Tullis Health InvestorsPalm Beach Gardens · $500K – $10Mvia John Tullis · led

Merck Global Health Innovation FundreportedRahway

TullisreportedPalm Beach Gardens

Reported raises · per SEC filings

Form D private placements

$86.8M disclosed across 10 of 16 rounds · 2016–2026

▶Undisclosed amountofferedApr 2026 · Other Health Care

Rule 506(b)